Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily

OBJECTIVES: Antiretroviral therapy during pregnancy is recommended to reduce the risk of mother-to-child transmission of HIV and for maternal care management. Physiological changes during pregnancy can affect pharmacokinetics, potentially altering pharmacological activity. We therefore evaluated the...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:HIV Med
Glavni autori: Zorrilla, CD, Wright, R, Osiyemi, OO, Yasin, S, Baugh, B, Brown, K, Coate, B, Verboven, P, Mrus, J, Falcon, R, Kakuda, TN
Format: Artigo
Jezik:Inglês
Izdano: BlackWell Publishing Ltd 2014
Teme:
Short Communications
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4231999/
https://ncbi.nlm.nih.gov/pubmed/23731450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hiv.12047
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items